Assessing the role of Chemokine (C–C motif) ligand 14 in AKI: a European consensus meeting

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Validation of Urinary C-C Motif Chemokine Ligand 14 for Persistent Severe AKI Using Clinical Adjudication2026
2. 2Performance of a Standardized Clinical Assay for Urinary C–C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury2022 · 61 citations
3. 3Assessment of urine CCL2 as a potential diagnostic biomarker for acute kidney injury and septic acute kidney injury in intensive care unit patients2024 · 3 citations
4. 445: LEVERAGING URINE BIOMARKERS TO PREDICT ACUTE KIDNEY INJURY IN CRITICALLY ILL CHILDREN2026
5. 5Comparative Performance of Novel and Standard Urinary Kidney Biomarkers for Prediction of Persistent Severe AKI and Long-Term Major Adverse Kidney Events2026